News

Freigeist-Fellow Dr. Laura Ewell develops a new new technique to identify brain cells within an intact functioning network. We talked to her about her research project, what fuels her curiosity and drives her as a researcher and a Freigeist.

For the first time, the lot luck decides in the funding initiative "Experiment!" on the eligibility of project applications. With this procedure, the Volkswagen Foundation enters new territory in the funding landscape.

Since 2014, the Foundation's Board of Trustees has been electing ten to fifteen Freigeist Fellows each year: These young research talents have an extraordinary research idea and are working at the borders of neighbouring fields or disciplines. In our second part of the interview, Dr. Johanna Brumberg and Dr. Oliver Grewe, program directors of the initiative, answer questions about the way to submitting an application and about the review process.

Since 2014, the Foundation's Board of Trustees has been electing ten to fifteen Freigeist Fellows each year: Young research talents in all disciplines with an extraordinary research idea, who tread new territory and are working at the borders of neighbouring fields or disciplines. What makes a "Freigeist" in the eyes of the Foundation and how can you apply for the fellowship program? Dr. Johanna Brumberg and Dr. Oliver Grewe, program directors of the initiative, answer these questions in our interview.

The Volkswagen Foundation supports professors three to five years after taking up their first tenured professorship at a university in Germany. The application deadline for 2018 is June 5. 

During the internationalen Nature Herrenhausen Symposium on November 2-3, 2017, current aspects of HIV infection, immunity, persistence and eradication research have been discussed. The summary report is now online!

The Herrenhausen Conference on November 27-29, 2017 was an interdisciplinary platform for developing risk reduction strategies for low-income communities threatened by natural hazards.

The International Workshop from October 11-13, 2017, aimed at evaluating current evidence for the nature and likelihood of genome editing risks and exploring potential for future developments and options for governance strategies.